Immunitybio Inc (IBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Sales | 4 | 5 | 12 | 8 | 14 |
| Gross Profit | 4 | 5 | 12 | 8 | 14 |
| Operating Expenses | 28,282 | 28,289 | 25,406 | 24,450 | 23,834 |
| Operating Income | -28,278 | -28,284 | -25,394 | -24,442 | -23,820 |
| Interest Expense | 106 | 33 | 34 | 393 | 154 |
| Other Income | 529 | 674 | 769 | 767 | 398 |
| Pre-tax Income | -27,855 | -27,643 | -24,659 | -24,068 | -23,576 |
| Income Tax | -123 | -124 | -172 | -99 | -124 |
| Net Income Continuous | -27,732 | -27,519 | -24,487 | -23,969 | -23,452 |
| Net Income | $-27,732 | $-27,519 | $-24,487 | $-23,969 | $-23,452 |
| EPS Basic Total Ops | -0.35 | -0.35 | -0.31 | -0.30 | -0.29 |
| EPS Basic Continuous Ops | -0.35 | -0.35 | -0.31 | -0.30 | -0.29 |
| EPS Diluted Total Ops | -0.35 | -0.35 | -0.31 | -0.30 | -0.29 |
| EPS Diluted Continuous Ops | -0.35 | -0.35 | -0.31 | -0.30 | -0.29 |
| EBITDA(a) | $-25,767 | $-26,460 | $-23,526 | $-22,623 | $-22,078 |